During the past decade, Hôpital Porte Madeleine conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Porte Madeleine" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Porte Madeleine" are "Ankylosing Spondylitis" (1 trials), "Glycogen Storage Disease Type II" (1 trials), "Pompe Disease Infantile-Onset" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Hôpital Porte Madeleine" in a lesser frequency.

Most popular intervention types in "Hôpital Porte Madeleine" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials), "Etanercept" (1 trials) and "Myozyme" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Porte Madeleine" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Porte Madeleine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Porte Madeleine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Porte Madeleine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".